Schmitt-Kopplin Lab

Mission: Chemical processes in human metabolic health. uHR-mass spec, NMR spectroscopy and mathematical modelling. Part of @HelmholtzMunich

[Schmitt-Kopplin Lab @ChemBioSys_muc]

…and finally the certificate in the sun ☀️🔖

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📣Announcement,announcement! 📣
Mr. Marco Matzka is now Dr. Marco Matzka 💪
Many congratulations to you! @Schmitt_Kopplin @TU_Muenchen @Health_talents

[Schmitt-Kopplin Lab @ChemBioSys_muc]

@michelletberger @msaid_de It was great having you with us!
Wish you lots of success and fun in your new role. 🔥💪🍀

[Schmitt-Kopplin Lab @ChemBioSys_muc]

@emergenceoflife Fantastic work by Philippe Diederich et al.

[HMGU-EUS - JPSchnitzlerLab @JPSchnitzler]

European oak metabolites shape digestion and fitness of the herbivore Tortrix viridana https://t.co/jbh2g7P75p

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌Curious about: How metal exposure affects the #Metallome & #Lipidome in C.elegans and how this relates to neurodegenerative diseases, such as Parkinson?
💡Check out our latest publication
🔄Bastian Blume @Schmitt_Kopplin @HelmholtzMunich @WWU_Muenster ⬇️ https://t.co/Avs63nlwVp

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌17 labs across the globe working to create a joint #reference for #FT-ICR MS blood #plasma profiling

💡 Large-Scale Interlaboratory DI-FT-ICR MS Comparability Study Employing Various Systems

⬇️https://t.co/jUQCajqVwP
🔄@Schmitt_Kopplin @bruker @HelmholtzMunich @TU_Muenchen

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌Still looking for an easy & robust method for analyzing free glycation products?
💡Please check out our latest paper about #HILIC-MS for untargeted profiling free #glycation products diversity
⬇️
https://t.co/gmTZG0OrOO
🔄@yan_yingfei @DHemmler @Schmitt_Kopplin @HelmholtzMunich

[Schmitt-Kopplin Lab @ChemBioSys_muc]

🤔Is Santa hiding between our instruments?? @bruker 🧲 @Agilent @Phenomenex 🫣🎅

[Schmitt-Kopplin Lab @ChemBioSys_muc]

@Health_talents @liesasalzer @Schmitt_Kopplin @wittingmichael1 @HelmholtzMunich Great @liesasalzer! We are very proud of you!

[Michael Witting @wittingmichael1]

I'n happy to share our latest article lead by my wonderful PhD student Eva-Maria Harrieder! Great work Eva 👍 https://t.co/1QUIAGnoPy

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌If you wonder: 🤔Did I report all important #chromatographic metadata? How can I automate and standardize this info?
💡Then check out our paper with suggestions📝!
🔄 Eva & @boeckerlab @rickdunnblade @wittingmichael1 @HelmholtzMunich @TU_Muenchen
⬇️https://t.co/oMeLYOBhi8

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌Post-COVID-19 syndrome? Look into my eyes!

💡Retinal microcirculation as objective #biomarker for chronic fatigue assessment in patients with #post-COVID syndrome.

🔄@marianna_lucio @Dr_B_Hohberger @HelmholtzMunich @UniFAU
➡️https://t.co/DSCVjlq43n

[Schmitt-Kopplin Lab @ChemBioSys_muc]

https://t.co/ky3LEsakV0 @MetabolitesMDPI

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌 Microbial metabolites in urine samples?
💡Our urine #NMR 🧲metabolomics workflow with metabolite identification developments shows how we can characterize microbial vs endogenous metabolites
🔄@ssHeinzmann @Schmitt_Kopplin @EPI_Helmholtz @HelmholtzMunich
⬇️

[Schmitt-Kopplin Lab @ChemBioSys_muc]

⬇️https://t.co/KZeioVo48N

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌Interested in #AI applications in high content screening?

💡Please read our latest paper about benchmarking
different #machinelearning & #deeplearning workflows in high-content screening #hcs
🔄@stanze_ @Schmitt_Kopplin @HelmholtzMunich Kenji & Kamyar from TOXI

[Schmitt-Kopplin Lab @ChemBioSys_muc]

Joining forces to tackle metabolic questions with NMR 🧲🩸💊@HelmholtzMunich @Sattler_lab

[Silke Heinzmann @ssHeinzmann]

Please resolve my signals! 🧲 Checking out the 💪 of @bruker ✨1.2 GHz✨ today! Thanks to @Sattler_lab for access and support! #nmrchat

[Schmitt-Kopplin Lab @ChemBioSys_muc]

We are at #cac2022 !
Please visit 🤝 Erwin Kupczyk at his Poster P17 📜 and chat 🗣 with him about „Benchmarking Machine Learning Approaches for Hit Detection in High-Content Screening“💡 @stanze_ @HelmholtzMunich

[Schmitt-Kopplin Lab @ChemBioSys_muc]

📌Diabetes drug discovery with high-content screening?
💡 Please check out our latest review describing combination of #HCS and untargeted #metabolomics to ameliorate early stage screening of #T2DM drugs
🔄@stanze_ @Schmitt_Kopplin @HelmholtzMunich
⬇️
https://t.co/TdyQv84SQs